All Posts By

Smartkarma Daily Briefs

Daily Brief Credit: Lucror Analytics – Morning Views Asia and more

By | Credit, Daily Briefs

In today’s briefing:

  • Lucror Analytics – Morning Views Asia


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Country Garden, Softbank Group, Xiaomi Corp, Sunny Optical
  • UST yields declined 2-3 bps across the curve yesterday, with limited catalysts on the macro front and amid a sell-off in equities. The yield on the 2Y UST fell 2 bps to 3.75%, while the yield on the 10Y UST declined 3 bps to 4.31%. Equities retreated, driven by a sell-off in tech stocks. The S&P 500 declined 0.6% to 6,411, while the Nasdaq slumped 1.5% to 21,315.
  • In the US, July housing starts rose 5.2% m-o-m (-1.8% e / 5.9% p) to an annualised 1.43 mn units. That said, the July (preliminary) building permits fell 2.8% m-o-m (-0.5% e / -0.1% p) to an annualised 1.35 mn units.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Kokusai Electric (6525 JP): Q1 Miss; FY Guidance Maintained and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Kokusai Electric (6525 JP): Q1 Miss; FY Guidance Maintained, 2H Ramp Critical, Valuation Discount
  • Rohm Co Ltd(6963 JP): Advancing from Breakdown to Breakthrough; Strong Outlook for Q2
  • Vikram Solar IPO – Riding India’s Renewable Energy Wave
  • Astera Labs: Initiation of Coverage -Taurus & Aries Product Diversification As a Key Growth Strategy!
  • Nittobo (3110 JP) – Q1 Solid, Guidance Retained; 2H Execution Key for AI-Led Growth
  • Intel In The Hot Seat: U.S. Government Eyes Stake As Chipmaker Stumbles
  • Jacobs Solutions: An Advanced Facilities & Water Sector Momentum for Future Revenue Growth & Project Execution!
  • CHIPS Act Money For Equity Stake, Pay For China Play? For Goodness Sake!
  • Broadridge Financial Solutions: These Are The 4 Biggest Challenges In Its Path In 2025 & Beyond!
  • IFF Expands Global Footprint as Emerging Markets Unlock New Revenue Streams!


Kokusai Electric (6525 JP): Q1 Miss; FY Guidance Maintained, 2H Ramp Critical, Valuation Discount

By Rahul Jain

  • Results: Q1 revenue ¥51.8B (–21% YoY) and OP ¥10.9B (–44%) came in weak, with DRAM softness offset partly by NAND strength.
  • Guidance: FY26/3 outlook (¥244B revenue, ¥55.2B OP) reiterated, implying a sharp 2H acceleration in shipments and margin recovery.
  • Valuation: Shares trade at ~11× EV/EBITDA, a discount to peers, but execution risk keeps the multiple constrained.

Rohm Co Ltd(6963 JP): Advancing from Breakdown to Breakthrough; Strong Outlook for Q2

By Sreemant Dudhoria,CFA

  • Advancing from Breakdown to Breakthrough:ROHM Co Ltd (6963 JP) returned to profitability in Q1FY25 on improved demand and cost controls with strong outlook for Q2.
  • Rohm is actively implementing structural reforms, with a priority on ensuring profitability in any market environment.  It is also drafting its second Medium-Term Management Plan for FY26 to FY28.
  • It continues to be available at significantly cheaper valuation versus peers of just 0.8x price to book. Also, it has been added to the Nikkei 225 Index recently.

Vikram Solar IPO – Riding India’s Renewable Energy Wave

By Sudarshan Bhandari

  • Vikram Solar’s IPO launch with INR 1,500 crore fresh issue underscores its ambition to fund large-scale expansion, boosting installed capacity from 4.5 GW to 20.5 GW by FY27.
  • A robust 10.3 GW order book and Tier-1 global recognition reinforce demand visibility and credibility, positioning the company strongly amid India’s accelerating renewable transition.
  • Execution risks in new facilities, raw material price volatility, and premium valuations temper the growth story, requiring cautious optimism from investors.

Astera Labs: Initiation of Coverage -Taurus & Aries Product Diversification As a Key Growth Strategy!

By Baptista Research

  • Astera Labs, in its second quarter of fiscal year 2025, showcased robust financial performance and strategic advancement in its market positioning.
  • The company reported revenue of $191.9 million, reflecting a 20% increase from the previous quarter and a notable 150% year-over-year rise.
  • This substantial revenue growth was attributed to increased demand in both its signal conditioning and switch fabric product lines, notably with the Scorpio P-Series switches.

Nittobo (3110 JP) – Q1 Solid, Guidance Retained; 2H Execution Key for AI-Led Growth

By Rahul Jain

  • Results: Q1 FY26 came in solid, with strength in Electronic Materials offsetting weakness in Insulation.
  • Guidance/Estimates: FY26 guidance was reiterated, and we retain our estimates, with 2H execution key.
  • Valuation: At ~9.5x EV/EBITDA FY26E, Nittobo looks inexpensive, with its monopoly T-glass exposure offering direct leverage to NVIDIA-driven AI/data center demand.

Intel In The Hot Seat: U.S. Government Eyes Stake As Chipmaker Stumbles

By Baptista Research

  • Intel is suddenly at the center of a high-stakes drama.
  • Just this month, the Trump administration reversed its public criticism of CEO Lip Bu Tan—who had been accused of being “conflicted” due to his past China ties—and moved into “constructive discussions” about a possible government equity stake in the company .
  • That shift followed a White House meeting that apparently reset the tone, with Trump calling Tan’s journey “amazing” after once demanding his resignation .

Jacobs Solutions: An Advanced Facilities & Water Sector Momentum for Future Revenue Growth & Project Execution!

By Baptista Research

  • Jacobs presented strong fiscal third-quarter 2025 results, with both adjusted EPS and revenue targets meeting or surpassing expectations.
  • The quarter was marked by a 25% increase in adjusted EPS to $1.62, buoyed by net revenue growth of 7% and substantial year-over-year margin expansion.
  • The company’s backlog grew 14% to a record $23 billion, and bookings maintained a positive trajectory, positioning Jacobs favorably for upcoming quarters.

CHIPS Act Money For Equity Stake, Pay For China Play? For Goodness Sake!

By William Keating

  • US commerce secretary Howard Lutnick confirmed that the US Administration is pursuing a strategy of converting CHIPS Act funding into equity stakes with Intel acting as its guinea pig
  • It seems clear that Mr. Lutnick is bent on applying the same formula with other beneficiaries of US CHIPs Act funding
  • CHIPs Act Dollars for Equity, Pay For China Play may seem like innovative ideas but in reality they are a slippery slope to confusion & chaos. Who or what’s next?

Broadridge Financial Solutions: These Are The 4 Biggest Challenges In Its Path In 2025 & Beyond!

By Baptista Research

  • Broadridge Financial Solutions presented a robust financial performance in its fiscal fourth quarter and full year 2025 results, signaling positive momentum and strategic positioning for future growth.
  • The company reported a 7% increase in recurring revenue on a constant currency basis and an 11% growth in adjusted earnings per share (EPS), in line with its long-term objectives.
  • This financial achievement was complemented by the strategic execution in key areas such as democratization and digitization of governance, capital markets innovation, and modernization of wealth management.

IFF Expands Global Footprint as Emerging Markets Unlock New Revenue Streams!

By Baptista Research

  • The recent financial results for International Flavors & Fragrances Inc. (IFF) reveal a balanced but challenging landscape for the company, marked by both growth strides and headwinds across various business segments.
  • In the second quarter of 2025, IFF reported a revenue increase of over 3% year-over-year, reaching just above $2.75 billion.
  • Additionally, the adjusted operating EBITDA grew by approximately 6% to $552 million, with a margin improvement of 50 basis points.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Samsung Electronics, Kokusai Electric , ROHM Co Ltd, Astera Labs , Intel Corp, Broadridge Financial Solutions, Inc, Comtech Telecommunications, Kyivstar Group, Leidos Holdings and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • US Government May Acquire Equity Stakes in Samsung Electronics and TSMC
  • Kokusai Electric (6525 JP): Q1 Miss; FY Guidance Maintained, 2H Ramp Critical, Valuation Discount
  • Rohm Co Ltd(6963 JP): Advancing from Breakdown to Breakthrough; Strong Outlook for Q2
  • Astera Labs: Initiation of Coverage -Taurus & Aries Product Diversification As a Key Growth Strategy!
  • Intel In The Hot Seat: U.S. Government Eyes Stake As Chipmaker Stumbles
  • Broadridge Financial Solutions: These Are The 4 Biggest Challenges In Its Path In 2025 & Beyond!
  • CHIPS Act Money For Equity Stake, Pay For China Play? For Goodness Sake!
  • Comtech Telecommun (CMTL) – Wednesday, May 21, 2025
  • Kyivstar (KYIV US): Structural Long – From Ukraine’s Resilience to Renewal; Uklon Embedded Value
  • Leidos Holdings: Initiation of Coverage- Expaning Border Security Tech But Will $3 Billion in Funding Fuel Sufficient Growth?


US Government May Acquire Equity Stakes in Samsung Electronics and TSMC

By Douglas Kim

  • According to Reuters, the US government may be interested in acquiring equity stakes in Samsung Electronics and TSMC in exchange for CHIPS and Science Act grants.
  • The US government is exploring ways to take equity stakes in these two Asian tech giants that have been expanding their semiconductor facilities in the United States.
  • If the US government decides to invest $10 billion each in Samsung Electronics and TSMC, they would represent about 3% and 1% of Samsung Electronics and TSMC’s market caps, respectively. 

Kokusai Electric (6525 JP): Q1 Miss; FY Guidance Maintained, 2H Ramp Critical, Valuation Discount

By Rahul Jain

  • Results: Q1 revenue ¥51.8B (–21% YoY) and OP ¥10.9B (–44%) came in weak, with DRAM softness offset partly by NAND strength.
  • Guidance: FY26/3 outlook (¥244B revenue, ¥55.2B OP) reiterated, implying a sharp 2H acceleration in shipments and margin recovery.
  • Valuation: Shares trade at ~11× EV/EBITDA, a discount to peers, but execution risk keeps the multiple constrained.

Rohm Co Ltd(6963 JP): Advancing from Breakdown to Breakthrough; Strong Outlook for Q2

By Sreemant Dudhoria,CFA

  • Advancing from Breakdown to Breakthrough:ROHM Co Ltd (6963 JP) returned to profitability in Q1FY25 on improved demand and cost controls with strong outlook for Q2.
  • Rohm is actively implementing structural reforms, with a priority on ensuring profitability in any market environment.  It is also drafting its second Medium-Term Management Plan for FY26 to FY28.
  • It continues to be available at significantly cheaper valuation versus peers of just 0.8x price to book. Also, it has been added to the Nikkei 225 Index recently.

Astera Labs: Initiation of Coverage -Taurus & Aries Product Diversification As a Key Growth Strategy!

By Baptista Research

  • Astera Labs, in its second quarter of fiscal year 2025, showcased robust financial performance and strategic advancement in its market positioning.
  • The company reported revenue of $191.9 million, reflecting a 20% increase from the previous quarter and a notable 150% year-over-year rise.
  • This substantial revenue growth was attributed to increased demand in both its signal conditioning and switch fabric product lines, notably with the Scorpio P-Series switches.

Intel In The Hot Seat: U.S. Government Eyes Stake As Chipmaker Stumbles

By Baptista Research

  • Intel is suddenly at the center of a high-stakes drama.
  • Just this month, the Trump administration reversed its public criticism of CEO Lip Bu Tan—who had been accused of being “conflicted” due to his past China ties—and moved into “constructive discussions” about a possible government equity stake in the company .
  • That shift followed a White House meeting that apparently reset the tone, with Trump calling Tan’s journey “amazing” after once demanding his resignation .

Broadridge Financial Solutions: These Are The 4 Biggest Challenges In Its Path In 2025 & Beyond!

By Baptista Research

  • Broadridge Financial Solutions presented a robust financial performance in its fiscal fourth quarter and full year 2025 results, signaling positive momentum and strategic positioning for future growth.
  • The company reported a 7% increase in recurring revenue on a constant currency basis and an 11% growth in adjusted earnings per share (EPS), in line with its long-term objectives.
  • This financial achievement was complemented by the strategic execution in key areas such as democratization and digitization of governance, capital markets innovation, and modernization of wealth management.

CHIPS Act Money For Equity Stake, Pay For China Play? For Goodness Sake!

By William Keating

  • US commerce secretary Howard Lutnick confirmed that the US Administration is pursuing a strategy of converting CHIPS Act funding into equity stakes with Intel acting as its guinea pig
  • It seems clear that Mr. Lutnick is bent on applying the same formula with other beneficiaries of US CHIPs Act funding
  • CHIPs Act Dollars for Equity, Pay For China Play may seem like innovative ideas but in reality they are a slippery slope to confusion & chaos. Who or what’s next?

Comtech Telecommun (CMTL) – Wednesday, May 21, 2025

By Value Investors Club

Key points (machine generated)

  • Comtech plans to announce the sale of its Public Safety / NG911 business unit, which has significant revenue and EBITDA.
  • The business unit’s valuation could range from $400 million to $800 million, impacting Comtech’s financial standing and debt alleviation.
  • A higher sale price could provide up to $300 million in net cash, greatly enhancing Comtech’s equity value.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Kyivstar (KYIV US): Structural Long – From Ukraine’s Resilience to Renewal; Uklon Embedded Value

By Vincent Fernando, CFA

  • Ukraine’s leading digital operator with 24m mobile and 1.1m broadband users, providing critical national infrastructure and direct exposure to the country’s recovery and EU-aligned digital renewal.
  • Uklon as a transformative asset. With 100m+ annual rides and 100k drivers, Uklon adds unicorn potential and positions Kyivstar to anchor high-frequency platforms powering Ukraine’s next economic chapter.
  • Robust financial profile with re-rating upside: US$1.2bn 2025E revenue, US$647m EBITDA, zero debt; trading at 5.2x EV/EBITDA vs peer 6.5x, with upside from ARPU convergence and reconstruction.

Leidos Holdings: Initiation of Coverage- Expaning Border Security Tech But Will $3 Billion in Funding Fuel Sufficient Growth?

By Baptista Research

  • Leidos’ second quarter results for 2025 reflected both positive growth and notable challenges.
  • The company recorded robust revenue growth of 4.8% year-to-date, achieving record profitability with a 15.2% EBITDA margin and a 28% increase in operating cash flow for the quarter.
  • These achievements were realized amidst a dynamic market environment and were attributed to Leidos’ strategic focus, centered on five growth pillars under their North Star 2030 strategy: space and maritime, energy infrastructure, digital modernization and cyber, mission software, and managed health services.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Vikram Solar, Nitto Boseki, Karman Holdings, Jacobs Solutions , IHI Corp, Hubbell Inc, Megatronix Inc., Kawasaki Heavy Industries, Dayforce and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Vikram Solar IPO – Riding India’s Renewable Energy Wave
  • Nittobo (3110 JP) – Q1 Solid, Guidance Retained; 2H Execution Key for AI-Led Growth
  • Karman Holdings Inc.(KRMN) Six Month Summary: A Model Debut That Opened the Door for Moonshots
  • Jacobs Solutions: An Advanced Facilities & Water Sector Momentum for Future Revenue Growth & Project Execution!
  • IHI Corporation (7013 JP) – Strong Orders, Weak Profits; Guidance Backloaded on Aero & Disposals
  • Vikram Solar IPO: Scaling Domestic Manufacturing Amid Policy Tailwinds and Execution Risks
  • Hubbell’s $825 Million DMC Power Bet: Could This Acquisition Be A Game Changer?
  • Megatronix Inc. Pre-IPO: Favorable Growth Drivers, But Losses and Concentration Risks Persist
  • Kawasaki Heavy (7012 JP) – Soft Start to FY26, Steep H2 Profit Ask Vs Guidance
  • Thoma Bravo Eyes Dayforce: Can The HR Tech Giant Become Private Equity’s Next Big Bet?


Vikram Solar IPO – Riding India’s Renewable Energy Wave

By Sudarshan Bhandari

  • Vikram Solar’s IPO launch with INR 1,500 crore fresh issue underscores its ambition to fund large-scale expansion, boosting installed capacity from 4.5 GW to 20.5 GW by FY27.
  • A robust 10.3 GW order book and Tier-1 global recognition reinforce demand visibility and credibility, positioning the company strongly amid India’s accelerating renewable transition.
  • Execution risks in new facilities, raw material price volatility, and premium valuations temper the growth story, requiring cautious optimism from investors.

Nittobo (3110 JP) – Q1 Solid, Guidance Retained; 2H Execution Key for AI-Led Growth

By Rahul Jain

  • Results: Q1 FY26 came in solid, with strength in Electronic Materials offsetting weakness in Insulation.
  • Guidance/Estimates: FY26 guidance was reiterated, and we retain our estimates, with 2H execution key.
  • Valuation: At ~9.5x EV/EBITDA FY26E, Nittobo looks inexpensive, with its monopoly T-glass exposure offering direct leverage to NVIDIA-driven AI/data center demand.

Karman Holdings Inc.(KRMN) Six Month Summary: A Model Debut That Opened the Door for Moonshots

By IPO Boutique

  • The specialist in missile defense and space systems, priced its upsized 23.0 million share offering at $22.00—$2.00 above the marketed range—and opened at $30.00 for a 36.3% gain.
  • The company completed a follow-on offering on July 24th, selling 21 million shares (upsized from 20 million) at $49.00.
  • With a successful follow-on behind it, better-than-expected results, and a robust cash position, Karman has set the benchmark for how to execute a space and defense IPO in 2025.

Jacobs Solutions: An Advanced Facilities & Water Sector Momentum for Future Revenue Growth & Project Execution!

By Baptista Research

  • Jacobs presented strong fiscal third-quarter 2025 results, with both adjusted EPS and revenue targets meeting or surpassing expectations.
  • The quarter was marked by a 25% increase in adjusted EPS to $1.62, buoyed by net revenue growth of 7% and substantial year-over-year margin expansion.
  • The company’s backlog grew 14% to a record $23 billion, and bookings maintained a positive trajectory, positioning Jacobs favorably for upcoming quarters.

IHI Corporation (7013 JP) – Strong Orders, Weak Profits; Guidance Backloaded on Aero & Disposals

By Rahul Jain

  • Q1 FY2026 results showed weak earnings (net profit –38% YoY) but a strong +29% YoY orderbook driven by Aero & Carbon Solutions.
  • Management retained FY2026 guidance, banking on aero aftermarket growth and disposal gains to drive a backloaded recovery.
  • Valuations (~14× EV/EBITDA, 24× P/E) look reasonable versus peers, but execution risks remain if disposals or aero demand underdeliver.

Vikram Solar IPO: Scaling Domestic Manufacturing Amid Policy Tailwinds and Execution Risks

By Rahul Jain

  • Funds Raised: The IPO aims to raise ~₹1,500 crore through a mix of fresh issue and OFS, strengthening balance sheet and funding expansion.
  • Future Plans & Objects: Proceeds will be deployed toward cell/module capacity expansion under the PLI scheme, working capital, and debt reduction.
  • The IPO benefits from strong policy and industry tailwinds, but execution challenges, import dependence, and margin volatility remain key risks.

Hubbell’s $825 Million DMC Power Bet: Could This Acquisition Be A Game Changer?

By Baptista Research

  • Hubbell Incorporated has been making headlines with a string of strong operational performances and strategic portfolio moves.
  • The company recently reported double-digit adjusted EPS growth in Q2 2025, supported by robust demand in grid infrastructure, sustained momentum in electrical solutions, and continued market tailwinds from grid modernization and electrification.
  • Now, Hubbell is set to add another piece to its growth puzzle: the $825 million all-cash acquisition of DMC Power, a provider of high-voltage connector technology for utility substation and transmission markets.

Megatronix Inc. Pre-IPO: Favorable Growth Drivers, But Losses and Concentration Risks Persist

By Hong Jie Seow

  • Megatronix Inc. (1888582D CH)  is looking to raise about US$100m in its upcoming Hong Kong IPO.
  • MI is an innovation-driven automotive technology company. MI focuses on developing and delivering AI-powered integrated domain control solutions that enable automakers to build the next generation of software-defined vehicles.
  • In this note, we look at the company’s past performance.

Kawasaki Heavy (7012 JP) – Soft Start to FY26, Steep H2 Profit Ask Vs Guidance

By Rahul Jain

  • Q1 revenue +10% YoY, with business profit up ~21% YoY on strength in Rolling Stock and ES&M, but headline net profit –72% YoY on FX headwinds and higher NCI drag.
  • Guidance / Revisions: FY26/3 guidance left unchanged, but steep H2 ask implies ~12% revenue and ~29% profit growth vs last year.
  • Outlook & Valuation: Near-term pressured by FX/tariffs, but aero/energy support medium-term growth; trades at ~14x NTM P/E, ~7.6x EV/EBITDA, a discount to peers.

Thoma Bravo Eyes Dayforce: Can The HR Tech Giant Become Private Equity’s Next Big Bet?

By Baptista Research

  • Dayforce reported strong financial performance in its second quarter of 2025, exceeding the high end of guidance across all key metrics.
  • The company observed a 14% growth in recurring revenue, excluding floating currency, on a constant currency basis, and a 420 basis point increase in adjusted EBITDA margin to 31.7%.
  • Free cash flow for the quarter reached $87.1 million, representing 18.7% of revenue, and the year-to-date figure climbed by 500 basis points to $106.6 million.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Daiichi Sankyo, Atlas Arteria, Pop Mart, HMM Co., Ltd., KB Financial, Samsung Electronics, Lynch Group Holdings, Hansoh Pharmaceutical Group and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for Sep25
  • Daiichi Sankyo Placement – US$1.2bn Deal but Momentum Isn’t the Best, Last Deal Didn’t Do Well
  • MV Australia Equal Weight Index Rebalance Preview: Three Potential Deletions in September
  • Hang Seng Indexes: Announcement Tomorrow; Potential Changes & Updated Flows
  • HMM Tender Side Play: Targeting a Basis Squeeze Ahead of Sep Expiry
  • UK CPI Trend Extends Excess In July
  • Korea’s Dividend Narrative Is Back: Unpacking the DP’s New Bill and Its Backstory
  • US Government May Acquire Equity Stakes in Samsung Electronics and TSMC
  • Lynch Group (LGL AU): (Another) Clean Offer From TPG
  • Hansoh Pharmaceutical (3692 HK): Placing Shares to Fund R&D Amid Stellar 1H Performance


Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for Sep25

By Brian Freitas

  • Post market close on Friday, Hang Seng Indexes will announce the changes for the Hang Seng Index (HSI INDEX) that will be implemented at the close on 5 September.
  • We highlight 6 stocks that have a higher probability of being added to the index. With the index committee entitled to a lot of discretion, there will be differences.
  • CATL completes 3 months of listing just prior to the review meeting date and is a dark horse candidate, though the committee could let the stock season for another quarter.

Daiichi Sankyo Placement – US$1.2bn Deal but Momentum Isn’t the Best, Last Deal Didn’t Do Well

By Sumeet Singh

  • A group of shareholders are looking to raise up to US$1.2bn via selling most of their stake in Daiichi Sankyo (4568 JP) .
  • While the deal shouldn’t come as a surprise, given the ongoing cross-shareholding unwind,  the last deal in the stock didn’t do well.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

MV Australia Equal Weight Index Rebalance Preview: Three Potential Deletions in September

By Brian Freitas

  • Nearing the end of the review period, we forecast no inclusions to the index in September. There could be up to 3 deletions at the review though.
  • Even if there are no constituent changes, capping changes will lead to one-way turnover of 3.8% and a round-trip trade of A$232m.
  • If there are 3 deletes as forecast, one-way turnover increases to 6.3% resulting in a round-trip trade of A$384m.

Hang Seng Indexes: Announcement Tomorrow; Potential Changes & Updated Flows

By Brian Freitas


HMM Tender Side Play: Targeting a Basis Squeeze Ahead of Sep Expiry

By Sanghyun Park

  • Most traders are starting in September, rolling into October. Sep/Oct spread volume has picked up unusually fast, clearly reflecting hedge demand linked to the tender
  • As September expiry approaches, basis-squeeze risk rises, likely pushing September cheap and October expensive, widening the spread — creating a clear side trade opportunity.
  • With a basis squeeze expected near September expiry, we could enter a Sep/Oct spread (short Sep, long Oct) and also watch for spot-futures decoupling to play the cash-futures spread.

UK CPI Trend Extends Excess In July

By Phil Rush

  • Another upside surprise in UK CPI inflation extended the accumulated drift to 1.3pp over the past year, yet was only 0.2pp above our old call.
  • This outcome matched the BoE’s latest call, with airfares driving the rise, and median pressures holding slightly above a target-consistent pace, so there is less policy impact.
  • The MPC was finely balanced in its support for August’s cut, and this rise will not lead dissenters to support past action, let alone another cut, which we still doubt occurs.

Korea’s Dividend Narrative Is Back: Unpacking the DP’s New Bill and Its Backstory

By Sanghyun Park

  • A new bill cutting Korea’s dividend tax hit the tape, giving local dividend plays an immediate boost on the news flow.
  • The presidential office is aligned on pushing the dividend tax below the 27.5% CGT floor. The new party leader is also tightly syncing with the Blue House to avoid clashes.
  • The DP’s tax cut move today puts the gov’s dividend narrative back in play with juice. We need setups to ride this theme.

US Government May Acquire Equity Stakes in Samsung Electronics and TSMC

By Douglas Kim

  • According to Reuters, the US government may be interested in acquiring equity stakes in Samsung Electronics and TSMC in exchange for CHIPS and Science Act grants.
  • The US government is exploring ways to take equity stakes in these two Asian tech giants that have been expanding their semiconductor facilities in the United States.
  • If the US government decides to invest $10 billion each in Samsung Electronics and TSMC, they would represent about 3% and 1% of Samsung Electronics and TSMC’s market caps, respectively. 

Lynch Group (LGL AU): (Another) Clean Offer From TPG

By David Blennerhassett

  • Lynch Group (LGL AU), an integrated wholesale floral play, has entered into a Scheme Implementation Deed with  Hasfarm Holdings and Darwin Aus Bidco – both of which are TPG entities.
  • Hasfarm is offering A$2.245/share, a 28.3% premium to last close. The consideration includes a fully franked dividend of A$0.09/share. It’s April 2021 IPO price was A$3.60/share.
  • The Offer has unanimous board support. 38.5% of the register is supportive. Hasfarm has also entered into a call option for 19.9% of shares out. Done deal.

Hansoh Pharmaceutical (3692 HK): Placing Shares to Fund R&D Amid Stellar 1H Performance

By Tina Banerjee

  • Hansoh Pharmaceutical Group (3692 HK) is placing 108M shares at the price of HK$36.30 per share. 65% of the proceeds will be used for the R&D of new innovative drugs.
  • Hansoh’s late-stage pipeline seems to be interesting, as its key focus areas being oncology and metabolic diseases, which are among the fast-growing therapeutic areas, with huge addressable patient population.
  • Hansoh has announced better-than-expected 1H25 result, with both revenue and net profit beating consensus. Innovative drugs revenue increased 22% YoY to RMB6B, contributing 82.7% of total revenue.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Health Care: Daiichi Sankyo, Hansoh Pharmaceutical Group , Ascletis Pharma Inc, Dogwood Therapeutics, Soligenix , Wuxi Biologics, Bayer , CytoSorbents and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Daiichi Sankyo Placement – US$1.2bn Deal but Momentum Isn’t the Best, Last Deal Didn’t Do Well
  • Hansoh Pharmaceutical (3692 HK): Placing Shares to Fund R&D Amid Stellar 1H Performance
  • Ascletis Pharma (1672 HK): Placement Bleak; Commercialization To Take Time; Lack Formidable Pipeline
  • DWTX: Over 50 Patients Enrolled Thus Far in Phase 2b Halneuron Trial Interim Read Out in 4Q25
  • SNGX: Dusquetide (SGX945) Granted Orphan Drug Designation for Behcet’s Disease
  • Wuxi Biologics (2269 HK) 25H1 – Concerns Behind the Performance Rebound
  • Bayer AG: An Insight Into Its Clinical Development
  • CTSO: CytoSorbents announced the De Novo denial on DrugSorb-ATR was upheld by the FDA. However


Daiichi Sankyo Placement – US$1.2bn Deal but Momentum Isn’t the Best, Last Deal Didn’t Do Well

By Sumeet Singh

  • A group of shareholders are looking to raise up to US$1.2bn via selling most of their stake in Daiichi Sankyo (4568 JP) .
  • While the deal shouldn’t come as a surprise, given the ongoing cross-shareholding unwind,  the last deal in the stock didn’t do well.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Hansoh Pharmaceutical (3692 HK): Placing Shares to Fund R&D Amid Stellar 1H Performance

By Tina Banerjee

  • Hansoh Pharmaceutical Group (3692 HK) is placing 108M shares at the price of HK$36.30 per share. 65% of the proceeds will be used for the R&D of new innovative drugs.
  • Hansoh’s late-stage pipeline seems to be interesting, as its key focus areas being oncology and metabolic diseases, which are among the fast-growing therapeutic areas, with huge addressable patient population.
  • Hansoh has announced better-than-expected 1H25 result, with both revenue and net profit beating consensus. Innovative drugs revenue increased 22% YoY to RMB6B, contributing 82.7% of total revenue.

Ascletis Pharma (1672 HK): Placement Bleak; Commercialization To Take Time; Lack Formidable Pipeline

By Tina Banerjee

  • Ascletis Pharma Inc (1672 HK) announced the placement of 52.4M shares for subscription at HK$16.45 per share.
  • The company intends to use 90% of proceeds for further R&D of its drug candidates with respect to both subcutaneously injected peptides and oral peptides, into clinical trials for obesity.
  • The company will take time to cash in fully from the commercialization efforts in near future, given the limited opportunity it has in terms of the drug pipeline basket.

DWTX: Over 50 Patients Enrolled Thus Far in Phase 2b Halneuron Trial Interim Read Out in 4Q25

By Zacks Small Cap Research

  • On August 13, 2025, Dogwood Therapeutics, Inc. announced financial results for the second quarter of 2025 and provided a business update.
  • Enrollment in the Phase 2b trial of Halneuron for the treatment of Chemotherapy Induced Neuropathic Pain (CINP) has reached 52 patients.
  • An interim data readout is expected in the fourth quarter of 2025.

SNGX: Dusquetide (SGX945) Granted Orphan Drug Designation for Behcet’s Disease

By Zacks Small Cap Research

  • On August 14, 2025, Soligenix, Inc. (SNGX) announced financial results for the second quarter of 2025 and provided a business update.
  • Following the release of promising Phase 2a clinical trial results for SGX945 (dusquetide) in Behcet’s Disease, the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to dusquetide for “treatment of Behcet’s Disease”.
  • The company has begun work on a subcutaneous formulation of SGX945, after which it is planning to perform a Phase 2b trial in Behcet’s Disease.

Wuxi Biologics (2269 HK) 25H1 – Concerns Behind the Performance Rebound

By Xinyao (Criss) Wang

  • WuXi Bio’s 25H1 growth was driven by XDC against the backdrop of BD wave of innovative drug assets. Coupled with biotech booming market, we witnessed obvious recovery in CXO’s performance. 
  • Intensive share reduction by major shareholders has weakened market confidence in long-term value. Given Li Ge’s rich experience in capital operation, WuXi Bio’s valuation potential may have been fully realized.
  • Current investment logic has shifted to the growth of overseas BD/licensing cooperation based on China’s low-priced but high-quality innovative drugs due to engineer dividend, which may have certain growth ceilings.

Bayer AG: An Insight Into Its Clinical Development

By Baptista Research

  • Bayer AG’s latest quarterly performance presents a mixed outlook, showing areas of growth and challenges.
  • In terms of financial results, the company’s sales remained flat in the first half of 2025, with second-quarter net sales growing slightly by 1% in currency and portfolio-adjusted terms.
  • Despite adverse currency movements, Bayer has successfully maintained a stable EBITDA, although foreign exchange headwinds impacted the top line with negative effects valued at around EUR 550 million.

CTSO: CytoSorbents announced the De Novo denial on DrugSorb-ATR was upheld by the FDA. However

By Zacks Small Cap Research

  • CytoSorbents is commercializing its E.U. approved CytoSorb blood purification technology to treat life-threatening conditions in the intensive care unit and cardiac surgery.
  • The company also seeks U.S. and Canadian approval of a second product, DrugSorb-ATR, to reduce perioperative bleeding risk in patients on blood thinners in cardiac surgery.
  • Based on the results of its STAR-T trial, the company submitted for FDA De Novo approval and Health Canada licensure in late 2024 and is currently navigating the appeal process with both agencies.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: KB Financial, Abacus Storage King, Nikkei 225, Country Garden Holdings Co, Chesapeake Financial Shares In, Toast and more

By | Daily Briefs, Financials

In today’s briefing:

  • Korea’s Dividend Narrative Is Back: Unpacking the DP’s New Bill and Its Backstory
  • Abacus Storage (ASK AU): Time To Get Some Exposure?
  • Abacus Storage King (ASK AU): Caution Is Warranted
  • Nikkei 225 Index Outlook: Key Buy Targets To Watch
  • Lucror Analytics – Morning Views Asia
  • CPKF: Second Quarter Diluted EPS Beats our Estimate by 0.04
  • Toast Inc.: Initiation Of Coverage- A Tale Of Growing Transaction Volume & Soaring Fintech Profits!


Korea’s Dividend Narrative Is Back: Unpacking the DP’s New Bill and Its Backstory

By Sanghyun Park

  • A new bill cutting Korea’s dividend tax hit the tape, giving local dividend plays an immediate boost on the news flow.
  • The presidential office is aligned on pushing the dividend tax below the 27.5% CGT floor. The new party leader is also tightly syncing with the Blue House to avoid clashes.
  • The DP’s tax cut move today puts the gov’s dividend narrative back in play with juice. We need setups to ride this theme.

Abacus Storage (ASK AU): Time To Get Some Exposure?

By David Blennerhassett

  • On the 7th April, the Ki Corporation/Public Storage (PSA US) consortium announced a NBIO, by way of a Scheme, for shares not held in Abacus Storage (ASK AU) at A$1.47/security.
  • ASK rejected the Offer on the 13th May. The Kirsh-led consortium bumped non-binding terms 14.7% to A$1.65/share on the 14th July, and was granted six weeks of due diligence.
  • DD expires on or around the 1st September. Nathan Kirsh directly/indirectly holds a 59.47% stake in ASK. Currently trading at a 7.5% spread to the indicative terms. 

Abacus Storage King (ASK AU): Caution Is Warranted

By Arun George

  • The six-week due diligence for Ki Corporation and Public Storage (PSA US)‘s A$1.65 offer for Abacus Storage King (ASK AU) ends on 1 September.
  • Some readers have asked if ASK is attractive at the current 7.5% gross spread. I think caution is warranted as there is a medium-to-high probability of no deal.
  • The probability of a binding scheme is low, as NSR will block it, and the Board requires a bump to recommend it. A takeover offer is not a credible alternative. 

Nikkei 225 Index Outlook: Key Buy Targets To Watch

By Nico Rosti

  • As predicted in our July 15th insight, the Nikkei 225 (NKY INDEX) rallied past 41k (reached near 44k) and now, as predicted by our latest WEEKLY HEAT MAP, went down.
  • The index reached a low of 42724 this week, it is only mildly oversold so far, probability of reversal is around 52% at the moment.
  • Key support levels to watch are 42577 (Q2) and 41606 (Q3). A file with all our PRICE/TIME model dataset for the Nikkei 225 is attached at the end, for your reference. 

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Country Garden, Softbank Group, Xiaomi Corp, Sunny Optical
  • UST yields declined 2-3 bps across the curve yesterday, with limited catalysts on the macro front and amid a sell-off in equities. The yield on the 2Y UST fell 2 bps to 3.75%, while the yield on the 10Y UST declined 3 bps to 4.31%. Equities retreated, driven by a sell-off in tech stocks. The S&P 500 declined 0.6% to 6,411, while the Nasdaq slumped 1.5% to 21,315.
  • In the US, July housing starts rose 5.2% m-o-m (-1.8% e / 5.9% p) to an annualised 1.43 mn units. That said, the July (preliminary) building permits fell 2.8% m-o-m (-0.5% e / -0.1% p) to an annualised 1.35 mn units.

CPKF: Second Quarter Diluted EPS Beats our Estimate by 0.04

By Zacks Small Cap Research

  • CPKF’s second quarter net earnings increased $0.1 million, or 4%, to $3.1 million year over year, while 2025’s second quarter diluted EPS rose $0.02, or 7%, to $0.67.
  • This was better than our estimate, which had called for a slight decline in net earnings of about $55,000 (off by about $50,000), as well as a $0.02 drop in EPS (off by $0.04).
  • We are increasing our diluted EPS estimate for 2025 by a nickel from $2.70 to $2.75, representing a 14% gain over 2024’s actual EPS of $2.42.

Toast Inc.: Initiation Of Coverage- A Tale Of Growing Transaction Volume & Soaring Fintech Profits!

By Baptista Research

  • Toast, Inc., a leading restaurant management platform, recently announced its second-quarter results for 2025, showcasing a strong performance with some encouraging metrics but also facing challenges as it navigates growth and expansion in various segments and geographies.
  • In the quarter ended June 30, 2025, Toast reported a 35% increase in recurring gross profit, achieving $161 million in adjusted EBITDA, with GAAP operating income reaching $80 million.
  • The company added a record 8,500 net new restaurant locations, bringing the total to approximately 148,000 locations served.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Pop Mart, Lynch Group Holdings, Smart Share Global, Goodai Global, Yum China Holdings , TSE Tokyo Price Index TOPIX, Yum! Brands Inc, JNBY Design Ltd, Guess? Inc and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Hang Seng Indexes: Announcement Tomorrow; Potential Changes & Updated Flows
  • Lynch Group (LGL AU): (Another) Clean Offer From TPG
  • Hillhouse’s Competing Bid Challenges Smart Share Global’s Management-Led Privatization
  • Lynch Group (LGL AU): TPG’s Scheme Offer
  • Goodai Global (Unlisted) – The Most Aggressive M&A Player in the Korean Cosmetics Industry
  • Yum China: Focus On Innovation & Customer Engagement to Foster Solid Growth Channels Via Advanced Digital Capabilities!
  • The Main Battlefield for Dissolution of Parent-Subsidiary Listings Will Shift to Standard Market
  • Yum! Brands: Focusing On Growth With AI Utilization Across 30
  • HK-Listed Apparel & Footwear Screener Aug 2025: Lever Style (1346 HK) Conference Call
  • GES: To Be Acquired by Authentic, Marciano Family and CEO for $16.75/GES Share


Hang Seng Indexes: Announcement Tomorrow; Potential Changes & Updated Flows

By Brian Freitas


Lynch Group (LGL AU): (Another) Clean Offer From TPG

By David Blennerhassett

  • Lynch Group (LGL AU), an integrated wholesale floral play, has entered into a Scheme Implementation Deed with  Hasfarm Holdings and Darwin Aus Bidco – both of which are TPG entities.
  • Hasfarm is offering A$2.245/share, a 28.3% premium to last close. The consideration includes a fully franked dividend of A$0.09/share. It’s April 2021 IPO price was A$3.60/share.
  • The Offer has unanimous board support. 38.5% of the register is supportive. Hasfarm has also entered into a call option for 19.9% of shares out. Done deal.

Hillhouse’s Competing Bid Challenges Smart Share Global’s Management-Led Privatization

By Special Situation Investments

  • Smart Share Global’s management consortium signed a definitive agreement to acquire the company at $1.25/ADS, later challenged by Hillhouse’s $1.77/ADS bid.
  • Hillhouse’s competing bid is 40% higher than management’s offer, with significant shareholder stakes potentially influencing the outcome.
  • EM’s business is unprofitable, with declining power bank rentals, but holds a net cash pile of $1.6/ADS.

Lynch Group (LGL AU): TPG’s Scheme Offer

By Arun George

  • Lynch Group Holdings (LGL AU) has entered a scheme implementation deed with TPG Inc (TPG US) at A$2.245, a 28.3% premium to the undisturbed price of A$1.75 (19 August).
  • Lynch has several substantial shareholders, which poses a vote risk. Encouragingly, four out of eight substantial shareholders are supportive.
  • The offer is attractive compared to historical trading ranges. The scheme meeting is estimated to be in November, with payment in December. 

Goodai Global (Unlisted) – The Most Aggressive M&A Player in the Korean Cosmetics Industry

By Douglas Kim

  • Goodai Global is the most aggressive M&A player in the Korean cosmetics industry. It has grown its business mainly through M&As.
  • It has achieved the strongest growth in sales and profits among the major Korean cosmetics companies in the past four years. 
  • In early August 2025, Goodai Global secured 800 billion won, with a pledge to go public within three years. Goodai’s value is estimated to be about 4 trillion won. 

Yum China: Focus On Innovation & Customer Engagement to Foster Solid Growth Channels Via Advanced Digital Capabilities!

By Baptista Research

  • Yum China Holdings, Inc. reported strong financial results for Q2 2025, marked by new record levels in revenue, operating profit, and operating margin.
  • The company’s dual-focused strategy emphasizing both same-store sales and system sales growth has yielded significant results.
  • Notably, overall same-store sales grew by 1%, driven by a 17% increase in same-store transactions at Pizza Hut and 5% system sales growth at KFC.

The Main Battlefield for Dissolution of Parent-Subsidiary Listings Will Shift to Standard Market

By Aki Matsumoto

  • Standard Market is home to companies that face challenges that fail to meet tradable shares ratio, can’t grow market capitalization, or feel it burdensome to meet governance and disclosure requirements.
  • TSE is likely to request companies listed on the Standard Market to disclose improvement measures in response to TSE’s requests, rather than raising the listing maintenance criteria.
  • 262 Standard Market companies are listed subsidiaries. It’s considered that the quickest way to improve the quality of the Standard Market is to delist these companies by eliminating parent-subsidiary listings.

Yum! Brands: Focusing On Growth With AI Utilization Across 30

By Baptista Research

  • Yum!
  • Brands reported its second quarter results for 2025, showcasing a mix of growth and strategic shifts amidst a challenging consumer environment.
  • The quarter was highlighted by system sales growth of 4%, with contributions from KFC International and Taco Bell US, which delivered positive transaction growth.

HK-Listed Apparel & Footwear Screener Aug 2025: Lever Style (1346 HK) Conference Call

By Sameer Taneja

  • Tariff confusion has hit stocks, but the names in focus continue to be resilient as they pass on the costs, and the future impact of demand is to be determined. 
  • The investing world is now searching for stocks that are not directly affected by Trump tariffs. Lever Style (1346 HK) is one such stock trading at 7.2x trailing PE.
  • With a trailing dividend yield of 6.2%, net cash of 27% of market cap, and impressive metrics on growth, this is a stock worth exploring. 

GES: To Be Acquired by Authentic, Marciano Family and CEO for $16.75/GES Share

By Small Cap Consumer Research

  • We are reiterating our projections and Buy rating and lowering our price target on GES to $16.75 (from $23.00) after the company announced an agreement with Authentic Brands, Maurice and Paul Marciano and Guess?
  • Chief Executive Officer Carlos Alberini to acquire Guess?
  • for $16.75 per GES share, a valuation for the company of $1.4 billion.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: UK CPI Trend Extends Excess In July and more

By | Daily Briefs, Macro

In today’s briefing:

  • UK CPI Trend Extends Excess In July
  • EA: Sticky Inflation Survives Euro’s Surge
  • India-China Economic Relations: Navigating Massive Imbalances and Strategic Dependencies
  • Separate Dividend Tax Plan in Korea: A Push for a 25% Rate for Top Bracket
  • Indonesia’s Surprise Summer Rate Cut
  • CX Daily: Li Auto Pins Its All-Electric Hopes on New SUV
  • New Zealand Extends Dovish Rate Cycle
  • Riksbank Holds at 2% Amid Fragile Outlook
  • Actinver Research – Macro Daily: Footwear tariffs
  • Actinver Research – Macro Daily: Inflation Forecast (1h-Aug)


UK CPI Trend Extends Excess In July

By Phil Rush

  • Another upside surprise in UK CPI inflation extended the accumulated drift to 1.3pp over the past year, yet was only 0.2pp above our old call.
  • This outcome matched the BoE’s latest call, with airfares driving the rise, and median pressures holding slightly above a target-consistent pace, so there is less policy impact.
  • The MPC was finely balanced in its support for August’s cut, and this rise will not lead dissenters to support past action, let alone another cut, which we still doubt occurs.

EA: Sticky Inflation Survives Euro’s Surge

By Phil Rush

  • Inflation’s surprise stickiness at 2% was confirmed in the Euro area’s final print, with pressures broad based and slightly above a target-consistent pace in most countries.
  • There has been little progress in inflation’s latent trend or our persistence-weighted measure, despite the Euro’s substantial and sustained appreciation.
  • Without dovish second-round effects, the ECB can look through a potential slowing in headline inflation to a tight labour market and persistent pressures, then not cut rates.

India-China Economic Relations: Navigating Massive Imbalances and Strategic Dependencies

By Viral Kishorchandra Shah

  • India’s $101B trade deficit with China highlights strategic economic vulnerabilities across key sectors.
  • Regulatory barriers since April 2020 sharply limited Chinese FDI, leading to negligible investments and shelved deals.
  • India’s import dependency is profound, spanning pharmaceuticals, electronics, chemicals, and railway components, exposing multiple strategic sectors to supply risks.

Separate Dividend Tax Plan in Korea: A Push for a 25% Rate for Top Bracket

By Douglas Kim

  • Democratic Party lawmaker Kim Hyun-jung has introduced a revised Income Tax Act that would lower the top tax rate on dividend income from 35% to 25%.
  • Given that this proposal is coming from the ruling Democratic Party, there is a fairly high probability that this could be passed into law in 3Q 2025.
  • We provide a list of 28 mid-cap/large cap stocks in Korea with more than 35% dividend payout and 3% or more dividend yield that could benefit from this new proposal.

Indonesia’s Surprise Summer Rate Cut

By Heteronomics AI

  • Bank Indonesia’s surprise 25bps cut to 5.00% signals proactive easing amid subdued inflation and global uncertainty.
  • The Rupiah’s strength and solid capital inflows provide policy space to support domestic growth despite external risks.
  • Further cuts are likely this year, contingent on exchange rate stability, fiscal support, and global economic developments.
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

CX Daily: Li Auto Pins Its All-Electric Hopes on New SUV

By Caixin Global

  • EVs / In Depth: Li Auto pins its all-electric hopes on new SUV
  • Corruption /Exclusive: Ex-IPO regulator found with up to 300 million yuan in cash
  • Exports /China’s ‘New Three’ exports power ahead, but trade with U.S. slumps

New Zealand Extends Dovish Rate Cycle

By Heteronomics AI

  • The RBNZ cut the OCR to 3% in August, matching consensus expectations amid stalled growth and stable medium-term inflation.
  • This decision was split, with a minority favouring a larger cut. Further reductions to 2.5% are likely unless inflation surprises persist.
  • Weak household demand and global uncertainty may extend the easing cycle, making future rate policy highly data-dependent.
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

Riksbank Holds at 2% Amid Fragile Outlook

By Heteronomics AI

  • The Riksbank held its rate at 2% while seeing above-target summer inflation as temporary.
  • Weak growth and a fragile labour market sustain rate-cut probability later in 2025.
  • The policy outlook hinges on fading inflation pressures, demand recovery, and global risks.
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

Actinver Research – Macro Daily: Footwear tariffs

By Actinver

  • The Mexican government announced a 25% tariff on footwear imports from countries without a trade agreement, aiming to curb unfair competition and protect the domestic industry.
  • The measure responds to complaints from the sector regarding the misuse of the Manufacturing, Maquiladora and Export Services Industry Program (IMMEX), created to import raw materials or semi-finished products without paying tariffs or taxes, process them in Mexico, and then export them.
  • However, according to the Ministry of Economy, in some cases the program has been used to bring finished footwear into the country and sell it in the domestic market.

Actinver Research – Macro Daily: Inflation Forecast (1h-Aug)

By Actinver

  • We expect inflation for the first half of August to stand at 0.08% bw, which would represent an increase in the annual rate from 3.48% to 3.59%.
  • Typically, inflation for this fortnight stands at 0.19% bw.
  • Our lower estimate is explained by a -1.10% bw decrease in livestock products, compared to the historical -0.27% bw. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Wilmar International, Del Monte Pacific, Geo Energy Resources and more

By | Daily Briefs, Singapore

In today’s briefing:

  • StubWorld: Wilmar Trading “Cheap” To YKA. Understandably.
  • Mid & Small Cap Surge: Liquidity, Inflows and Big Movers Since May
  • 10 in 10 with Geo Energy Resources – Bridging the gap of Energy and Infrastructure


StubWorld: Wilmar Trading “Cheap” To YKA. Understandably.

By David Blennerhassett


Mid & Small Cap Surge: Liquidity, Inflows and Big Movers Since May

By Geoff Howie

  • Oxley Holdings’ ADT surged to S$0.583 million since May, a 10.6× increase, with S$5.3 million profit before tax in 1HFY25.
  • UOB-Kay Hian Holdings recorded S$23.09 million net institutional inflow, with P/E ratio rising from 7x to 10x.
  • Non-index mid and small cap stocks attracted over S$100 million net institutional inflows since May, led by UOBKH and CSE Global.

10 in 10 with Geo Energy Resources – Bridging the gap of Energy and Infrastructure

By Geoff Howie

  • Geo Energy’s dividend policy commits to at least 30% of profit, with recent dividends showing a 25% increase.
  • In 1H2025, Geo Energy nearly doubled sales volume, boosting revenue by 71% and achieving US$20.1 million net profit.
  • Geo Energy’s integrated infrastructure supports revenue diversification through toll and jetty usage fees, enhancing financial stability.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars